The Pharmaceutical Industry Key trends and strategic issues shaping the industry

Introduction

Datamonitor has identified the key trends and events that impacted the pharmaceutical market on a macro-environmental and corporate strategy level in 2006. These range from the continuation of long term trends such as the focus on cost containment to more recent impacts such as the effects of Medicare Part D and the increasing power of the Democratic part in the US.

Scope of this report

Overview of the key macro-environmental trends driving industry change in 2006 and going forward into 2007

Review of major M&A deals in the pharma, biotech and generic sector in 2006

Analysis of the corporate strategies that companies in the pharmaceutical market are using to counter the challenges that they face

Research and analysis highlights

To overcome the poor R&D productivity that has characterized the pharmaceutical industry over the last few years, companies are being forced to re-evaluate R&D strategies. Companies are continuing to use licensing and acquisitions along with better prioritised spending and more structured decision making in an effort to deliver improved returns.

Pharma companies turned to a range of inorganic growth strategies in 2006 to improve sales and profit. This has allowed branded companies to expand their geographical presence, while enhancing the strength of their pipelines, frequently with the acquisition of small Pharma and biotechs providing additional products and supplementary technologies.

The role of emerging markets in the pharmaceutical industry is changing: not only do markets such as India and China represent significant targets for growth because of their rapid economic expansion, but with the globalization of the industry, manufacturers are increasingly outsourcing and offshoring numerous functions there.

Key reasons to read this report

Identify the key trends that have shaped the pharmaceutical industry in 2006

Weigh up which factors are likely to have a significant impact on the industry going forward into 2007

Understand how these factors will impact drug developers

Published: 14 February 2007

Format: PDF
Table of Contents
Price: $5,700.00 / GBP2,964.00